Effects of Postoperative Intravitreal Injections on Outcomes of Traditional Glaucoma Surgery in Patients with Preoperative Intravitreal Injections

被引:2
作者
Chang, Enchi K. [1 ]
Gupta, Sanchay [1 ]
Hall, Nathan [1 ]
Neeson, Cameron E. [2 ]
Chang, Ta C. [3 ]
Sola-Del Valle, David A. [1 ]
机构
[1] Harvard Med Sch, Massachusetts Eye & Ear, Boston, MA 02115 USA
[2] Massachusetts Eye & Ear, Boston, MA USA
[3] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA
来源
OPHTHALMOLOGY GLAUCOMA | 2022年 / 5卷 / 02期
关键词
Ahmed; Baerveldt; Glaucoma; Glaucoma drainage device; Glaucoma drainage implant; Intravitreal injection; Trabeculectomy; Tube; Surgical outcomes; AHMED VALVE SURGERY; NEOVASCULAR GLAUCOMA; COMBINED TRABECULECTOMY; BEVACIZUMAB; IMPLANTATION; RANIBIZUMAB; EFFICACY; ASSOCIATION; CONBERCEPT;
D O I
10.1016/j.ogla.2021.08.007
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To compare outcomes of glaucoma drainage device (GDD) implantation and trabeculectomies with and without postoperative intravitreal injections (IVIs) in glaucoma patients with a history of preoperative IVIs. Design: Retrospective cohort study. Participants: A total of 133 eyes of 133 glaucoma patients who underwent GDD implantation or trabecu-lectomy with at least 1 IVI preoperatively between January 2005 and October 2020 at Massachusetts Eye and Ear. Methods: Chart review of glaucoma patients with traditional glaucoma surgery and at least 1 IVI before surgery. All statistical analyses were conducted with R statistical programming software. Main Outcome Measures: Intraocular pressure (IOP), medication burden, best-corrected visual acuity (BCVA), Kaplan-Meier success rates, adjusted hazard ratios (HRs), and complications. Results: Baseline demographics were similar between the groups with and without postoperative IVIs. The group with postoperative IVIs had a higher proportion of diabetic retinopathy and retinal vascular occlusions than the group without postoperative IVIs, which had more eyes with age-related macular degeneration. Intraocular pressure, medication burden, and visual acuity were similar between groups at all time points except for IOP at 6 weeks, which was lower in the group with postoperative IVIs. The group with postoperative IVIs had significantly more preoperative IVIs than the group without postoperative IVIs (6.6 vs. 3.3, P = 0.017). For success defined as IOP reduction > 20% with 5 < IOP < 21 mmHg, Kaplan-Meier analyses demonstrated similar success rates between groups with and without IVIs. When stratified by the number of IVIs, success rates for the group with 7 or more IVIs were significantly higher than the success rates for the group with 0-6 IVIs (P = 0.005). Each additional postoperative IVI resulted in a 7.2% decrease in the hazard of failure to achieve our stated success criteria. With regard to late complications, the group with postoperative IVIs had a higher incidence of vitreous hemorrhage (18.5% vs. 3.2%, P = 0.039) than the group without postoperative IVIs. Conclusions: A higher number of postoperative IVIs, specifically 7 or more IVIs, may be associated with improved success rates of traditional glaucoma surgery in glaucoma patients who received IVIs before surgery. Ophthalmology Glaucoma 2022;5:219-228 2021 by the American Academy of Ophthalmology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:219 / 228
页数:10
相关论文
共 25 条
[1]   Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing ahmed glaucoma valve implantation: 2-year follow-up [J].
Arcieri, Enyr S. ;
Paula, Jayter S. ;
Jorge, Rodrigo ;
Barella, Kleyton A. ;
Arcieri, Rafael S. ;
Secches, Danilo J. ;
Costa, Vital P. .
ACTA OPHTHALMOLOGICA, 2015, 93 (01) :E1-E6
[2]   Adjunctive Intravitreal Bevacizumab-Combined Trabeculectomy Versus Trabeculectomy Alone in the Treatment of Neovascular Glaucoma [J].
Chen, Chih-Hsin ;
Lai, Ing-Chou ;
Wu, Pei-Chang ;
Chen, Yung-Jen ;
Chen, Yi-Hao ;
Lee, Jong-Jer ;
Liu, Ya-Chi ;
Kuo, Hsi-Kung .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2010, 26 (01) :111-118
[3]   The Ahmed Versus Baerveldt Study Five-Year Treatment Outcomes [J].
Christakis, Panos G. ;
Kalenak, Jeffrey W. ;
Tsai, James C. ;
Zurakowski, David ;
Kammer, Jeffrey A. ;
Harasymowycz, Paul J. ;
Mura, Juan J. ;
Cantor, Louis B. ;
Ahmed, Iqbal I. K. .
OPHTHALMOLOGY, 2016, 123 (10) :2093-2102
[4]   Intravitreal ranibizumab as an adjunct for Ahmed valve surgery in open-angle glaucoma: a pilot study [J].
Desai, Rajen U. ;
Singh, Kuldev ;
Lin, Shan C. .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 41 (02) :155-158
[5]   Effects of Intravitreal Anti-VEGF Therapy on Glaucoma-like Progression in Susceptible Eyes [J].
Du, Jeanette ;
Patrie, James T. ;
Prum, Bruce E. ;
Netlana, Peter A. ;
Shildkrot, Yevgeniy .
JOURNAL OF GLAUCOMA, 2019, 28 (12) :1035-1040
[6]   Association of Repeated Intravitreous Bevacizumab Injections With Risk for Glaucoma Surgery [J].
Eadie, Brennan D. ;
Etminan, Mahyar ;
Carleton, Bruce C. ;
Maberley, David A. ;
Mikelberg, Frederick S. .
JAMA OPHTHALMOLOGY, 2017, 135 (04) :363-368
[7]   Three-Year Follow-up of the Tube Versus Trabeculectomy Study [J].
Gedde, Steven J. ;
Schiffman, Joyce C. ;
Feuer, William J. ;
Herndon, Leon W. ;
Brandt, James D. ;
Budenz, Donald L. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2009, 148 (05) :670-684
[8]   The Effect of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure and Glaucoma A Report by the American Academy of Ophthalmology [J].
Hoguet, Ambika ;
Chen, Philip P. ;
Junk, Anna K. ;
Mruthyunjaya, Prithvi ;
Nouri-Mahdavi, Kouros ;
Radhakrishnan, Sunita ;
Takusagawa, Hana L. ;
Chen, Teresa C. .
OPHTHALMOLOGY, 2019, 126 (04) :611-622
[9]   Beneficial Effects of Adjuvant Intravitreal Bevacizumab Injection on Outcomes of Ahmed Glaucoma Valve Implantation in Patients with Neovascular Glaucoma: Systematic Literature Review [J].
Hwang, Hyung Bin ;
Han, Jae Wook ;
Yim, Hye Bin ;
Lee, Na Young .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2015, 31 (04) :198-203
[10]   Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study [J].
Inatani, Masaru ;
Higashide, Tomomi ;
Matsushita, Kenji ;
Nagasato, Daisuke ;
Takagi, Hitoshi ;
Ueki, Mari ;
Takai, Yasuyuki ;
Miyazaki, Ken ;
Iwamoto, Yuji ;
Kobayashi, Masato ;
Leal, Sergio .
ADVANCES IN THERAPY, 2021, 38 (02) :1106-1115